Vitalis Care is nominated for the 2026 Hospice News Product of the Year Award. We'd love your support — every vote counts.
Cast your vote
Vitalis Care is nominated for the 2026 Hospice News Product of the Year Award. We'd love your support — every vote counts.
Not sure which Vitalis Care solution is right for you?
Share of hospice discharges where the patient leaves alive
The share of a hospice's discharges in which the patient leaves the benefit alive; nationally approximately 19.0% in FY2024 and a primary program-integrity signal CMS uses to identify outlier enrollment and billing patterns.
The live discharge rate is the share of a hospice's discharges in which the patient leaves the benefit alive rather than dying in hospice care, whether through revocation, transfer, moving out of the service area, or a determination that the patient is no longer terminally ill. Nationally the rate was about 19.0% in FY2024 (CMS Hospice Monitoring Report, April 2025, https://www.cms.gov/files/document/hospice-monitoring-report-2025.pdf).
CMS tracks live discharges as a program-integrity signal because unusually high rates can indicate premature admission, inappropriate enrollment, or discharges timed to manage financial exposure. The national live discharge rate rose from 16.0% in FY2020 to 19.0% in FY2024 (CMS Hospice Monitoring Report, April 2025, https://www.cms.gov/files/document/hospice-monitoring-report-2025.pdf). Live discharges interact with the aggregate cap because each discharge and readmission affects the proportional beneficiary count, and a pattern of discharging long-stay patients before year-end to reduce cap liability draws scrutiny. Live discharge behavior is also one of the utilization dimensions CMS folds into the finalized Service and Spending Variation Index (SSVI) for oversight and public transparency (CMS FY2027 final rule fact sheet)[1]. Certain live discharges are clinically appropriate; the risk is in the pattern, not the individual event.
Live discharge rates materially above the national benchmark draw program-integrity review because elevated rates can signal premature admission, inappropriate enrollment, or financially motivated discharge practices. Regulators examine live discharge rates in conjunction with long-stay and cap data because the combination can indicate that discharges are timed to manage aggregate cap exposure rather than reflect genuine clinical improvement. No-longer-terminally-ill determinations and patient-initiated revocations are clinically appropriate events; their defensibility depends on documented clinical rationale — the same documentation that distinguishes appropriate discharge from a pattern that warrants audit. The approximately 19.0% national rate in FY2024 is the publicly available baseline against which individual hospice rates are compared.
Any discharge in which the patient leaves hospice alive, including revocation, transfer to another hospice, moving out of the service area, or a determination that the patient is no longer terminally ill.
The national rate was approximately 19.0% in FY2024, so rates materially above that draw regulatory attention (CMS Hospice Monitoring Report, April 2025, https://www.cms.gov/files/document/hospice-monitoring-report-2025.pdf).
Because high rates can signal premature or inappropriate admissions, or discharges timed to manage aggregate cap exposure, all of which are program-integrity concerns (CMS FY2027 final rule fact sheet)[1].
Vitalis Care is the end-of-life care app that helps hospices deliver compassionate care — while staying on top of schedules, field operations, documentation, compliance, and reimbursement.
Powered By nextbracket.io
